Chapter 7. Poxviral Vectors for Cancer Vaccines: State of the Art

  1. Rimas Orentas PhD2,
  2. James W. Hodge PhD3 and
  3. Bryon D. Johnson PhD4
  1. Elizabeth K. Wansley PhD

Published Online: 1 MAR 2007

DOI: 10.1002/9780470170113.ch7

Cancer Vaccines and Tumor Immunity

Cancer Vaccines and Tumor Immunity

How to Cite

Wansley, E. K. (2007) Poxviral Vectors for Cancer Vaccines: State of the Art, in Cancer Vaccines and Tumor Immunity (eds R. Orentas, J. W. Hodge and B. D. Johnson), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470170113.ch7

Editor Information

  1. 2

    Departments of Pediatrics, Medicine, Microbiology and Molecular Genetics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA

  2. 3

    Department of Medical Biology, University of Tennessee Medical Center and Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

  3. 4

    Department of Pediatrics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin., Milwaukee, WI, USA

Author Information

  1. Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Publication History

  1. Published Online: 1 MAR 2007
  2. Published Print: 22 JAN 2008

ISBN Information

Print ISBN: 9780470074749

Online ISBN: 9780470170113

SEARCH

Keywords:

  • poxviral vectors and cancer vaccines;
  • vaccinia vectors in cytokine expression;
  • Modified vaccinia Ankara (MVA)

Summary

This chapter contains sections titled:

  • Introduction

  • Viral Vectors for Cancer Therapy

  • Tumor-Associated Antigens

  • Using Vaccinia Vectors to Express Cytokines

  • Combination Therapies

  • Modified Vaccinia Ankara

  • Conclusions

  • Acknowledgments

  • References